0LI: 3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam
ide
0LI is a Ligand Of Interest in 8S17 designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 8S17_0LI_A_1001 | 83% | 49% | 0.081 | 0.943 | 0.93 | 0.93 | 1 | 2 | 1 | 0 | 100% | 1 |
| 8S17_0LI_B_1001 | 72% | 50% | 0.097 | 0.924 | 0.93 | 0.9 | 1 | 2 | 1 | 0 | 100% | 1 |
| 9GUA_0LI_D_204 | 97% | 65% | 0.052 | 0.973 | 0.57 | 0.63 | 1 | 1 | 0 | 0 | 100% | 1 |
| 6P3D_0LI_A_1001 | 96% | 5% | 0.053 | 0.968 | 2.28 | 2.77 | 10 | 16 | 0 | 0 | 100% | 1 |
| 4V01_0LI_B_1770 | 95% | 25% | 0.057 | 0.967 | 1.11 | 1.8 | 2 | 11 | 1 | 0 | 100% | 1 |
| 6TU9_0LI_A_801 | 89% | 59% | 0.074 | 0.958 | 0.66 | 0.76 | 2 | 2 | 0 | 0 | 100% | 1 |
| 4C8B_0LI_A_1000 | 89% | 10% | 0.073 | 0.956 | 1.49 | 2.67 | 6 | 19 | 1 | 0 | 100% | 1 |
